Kenyan researchers have successfully begun Covid-19 vaccine trials after the first two participants received the jab developed by the University of Oxford University and AstraZeneca.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted